Lee JS - Search Results

1

Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.

Glisson B, Komaki R, Lee JS, Shin DM, Fossella F, Murphy WK, Kurie J, Perez-Soler R, Schea R, Vadhan-Raj S. Glisson B, et al. Among authors: lee js. Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):331-6. doi: 10.1016/s0360-3016(97)00709-8. Int J Radiat Oncol Biol Phys. 1998. PMID: 9457817 Clinical Trial.

2

Systemic treatment of non-small-cell lung cancer.

Lenzi R, Fossella FV, Lee JS. Lenzi R, et al. Among authors: lee js. Compr Ther. 1992 Mar;18(3):27-30. Compr Ther. 1992. PMID: 1315236 Review. No abstract available.

3

Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.

Shin DM, Dhingra HM, Lee JS, Fossella FV, Murphy WK, Hong WK. Shin DM, et al. Among authors: lee js. Am J Clin Oncol. 1992 Jun;15(3):194-9. doi: 10.1097/00000421-199206000-00003. Am J Clin Oncol. 1992. PMID: 1317094 Clinical Trial.

4

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.

5

Ifosfamide with mesna uroprotection in the management of lung cancer.

Holoye PY, Glisson BS, Lee JS, Dhingra HM, Murphy WK, Umsawasdi T, Levy JK, Jeffries D, Raber MN, Hong WK. Holoye PY, et al. Among authors: lee js. Am J Clin Oncol. 1990 Apr;13(2):148-55. doi: 10.1097/00000421-199004000-00012. Am J Clin Oncol. 1990. PMID: 2156418

6

Primary chemotherapy of brain metastasis in small-cell lung cancer.

Lee JS, Murphy WK, Glisson BS, Dhingra HM, Holoye PY, Hong WK. Lee JS, et al. J Clin Oncol. 1989 Jul;7(7):916-22. doi: 10.1200/JCO.1989.7.7.916. J Clin Oncol. 1989. PMID: 2544685 Clinical Trial.

7

Phase II pilot study with cisplatin, etoposide, and continuous-infusion 5-fluorouracil in metastatic non-small cell lung cancer.

Lee JS, Dhingra HM, Chiuten DF, Holoye PY, Jeffries D, Murphy WK, Umsawasdi T, Neidhart JA. Lee JS, et al. Am J Clin Oncol. 1987 Dec;10(6):512-4. doi: 10.1097/00000421-198712000-00010. Am J Clin Oncol. 1987. PMID: 2825509

8

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.

Fossella FV, Lee JS, Berille J, Hong WK. Fossella FV, et al. Among authors: lee js. Semin Oncol. 1995 Apr;22(2 Suppl 4):22-9. Semin Oncol. 1995. PMID: 7740327 Review.

9

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

Fossella FV, Lee JS, Shin DM, Calayag M, Huber M, Perez-Soler R, Murphy WK, Lippman S, Benner S, Glisson B, et al. Fossella FV, et al. Among authors: lee js. J Clin Oncol. 1995 Mar;13(3):645-51. doi: 10.1200/JCO.1995.13.3.645. J Clin Oncol. 1995. PMID: 7884425 Clinical Trial.

10

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

Fossella FV, Lee JS, Murphy WK, Lippman SM, Calayag M, Pang A, Chasen M, Shin DM, Glisson B, Benner S, et al. Fossella FV, et al. Among authors: lee js. J Clin Oncol. 1994 Jun;12(6):1238-44. doi: 10.1200/JCO.1994.12.6.1238. J Clin Oncol. 1994. PMID: 7911160 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,840 results

Search Page

Filters